Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Mortality and Cause of Death in Multiple Sclerosis: Findings from a Prospective Population-Based Cohort in Bizkaia, Basque Country, Spain.
Structural features of the Nogo receptor signaling complexes at the neuron/myelin interface.
Deep-brain stimulation for Parkinson's disease.
Myelin Basic Protein and a Multiple Sclerosis-related MBP-peptide Bind to Oligonucleotides.
The Gut Microbiome and the Brain.
Effects of Physical Exercise on Neuroinflammation, Neuroplasticity, Neurodegeneration, and Behavior: What We Can Learn From Animal Models in Clinical Settings.
ARP2/3 complex is required for directional migration of neural stem cell-derived oligodendrocyte precursors in electric fields.
Treadmill training in multiple sclerosis: can body weight support or robot assistance provide added value? A systematic review.
Anti-AQP(4) antibody in idiopathic acute transverse myelitis with recurrent clinical course: frequency of positivity and influence in prognosis.
Medical and Nonstroke Neurologic Causes of Acute, Continuous Vestibular Symptoms.
Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis-establishing disease prognosis and monitoring patients.
Expression Analysis of CB2-GFP BAC Transgenic Mice.
Discovery of A-971432, an Orally Bioavailable Selective Sphingosine-1-Phosphate Receptor 5 (S1P5) Agonists for the Potential Treatment of Neurodegenerative Disorders.
Cytokines and matrix metalloproteinases in the cerebrospinal fluid of patients with acute transverse myelitis: an outcome analysis.
Management of faecal incontinence and constipation in adults with central neurological diseases.
Critical role of activation induced cytidine deaminase in Experimental Autoimmune Encephalomyelitis.
A novel method for calculating prevalence of multiple sclerosis in Australia.
Absence of systemic oxidative stress and increased CSF prostaglandin F2α in progressive MS.
Update on multiple sclerosis treatments.
Glial Cell Development and Function in Zebrafish.
Seizure Drug May Help in MS Eye Disease
High-mobility group box 1 in multiple sclerosis.
Supporting work for people with multiple sclerosis.
Multiple sclerosis registries in Europe - results of a systematic survey.
Severe Bilateral Heterotopic Ossification in a Patient With Multiple Sclerosis.
Pages
« first
‹ previous
…
319
320
321
322
323
324
325
326
327
…
next ›
last »